Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

NCT06278545 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced or Metastatic Small Bowel Adenocarcinoma

Interventions

DRUG: modified FOLFORINOX
DRUG: Modified FOLFOX

Sponsor

Centre Hospitalier Universitaire Dijon